牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

君实生物（688180）

5.6

综合诊断：5.6分打败了95%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
-
长期趋势：
已有209家主力机构披露2024-12-31报告期持股数据，持仓量总计2.52亿股，占流通A股32.93%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.3分

7.2分

5.5分

4.2分

6.5分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.3技术面打败了78%的股票技术面评分前10的股票

近期的平均成本为37.95元。

技术面得分最高的股票

平均成本

近期的平均成本为37.95元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"37.95","date":1751966803,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。

[{"date":"2025.07.09","stock":"0.16","trade":"-0.28","ind":"-0.13"},{"date":"2025.07.08","stock":"-0.26","trade":"0.18","ind":"0.70"},{"date":"2025.07.07","stock":"-5.57","trade":"-1.65","ind":"0.02"},{"date":"2025.07.04","stock":"5.98","trade":"0.46","ind":"0.32"},{"date":"2025.07.03","stock":"7.18","trade":"2.86","ind":"0.18"},{"date":"2025.07.02","stock":"-0.78","trade":"-1.57","ind":"-0.09"},{"date":"2025.07.01","stock":"5.00","trade":"2.52","ind":"0.39"},{"date":"2025.06.30","stock":"0.50","trade":"1.47","ind":"0.59"},{"date":"2025.06.27","stock":"-0.76","trade":"0.85","ind":"-0.70"},{"date":"2025.06.26","stock":"-2.52","trade":"-1.31","ind":"-0.22"},{"date":"2025.06.25","stock":"-1.16","trade":"0.29","ind":"1.03"},{"date":"2025.06.24","stock":"1.84","trade":"1.81","ind":"1.15"},{"date":"2025.06.23","stock":"5.15","trade":"1.50","ind":"0.65"},{"date":"2025.06.20","stock":"-2.05","trade":"0.27","ind":"-0.07"},{"date":"2025.06.19","stock":"-1.46","trade":"-1.80","ind":"-0.79"},{"date":"2025.06.18","stock":"-1.24","trade":"-1.20","ind":"0.04"},{"date":"2025.06.17","stock":"-3.10","trade":"-1.63","ind":"-0.04"},{"date":"2025.06.16","stock":"-0.91","trade":"-0.12","ind":"0.35"},{"date":"2025.06.13","stock":"-6.65","trade":"-2.82","ind":"-0.75"},{"date":"2025.06.12","stock":"5.54","trade":"1.54","ind":"0.01"},{"date":"2025.06.11","stock":"-1.03","trade":"-1.03","ind":"0.52"}]

君实生物,上证指数,生物制品指数

压力支撑

该股压力位为37.72元，支撑位为36.95元。

[{"text":"\u538b\u529b\u4f4d","value":"37.72","date":1751990400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"36.95","date":1751990400,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：7.2资金面打败了97%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：07月09日 20:41

机构今日流向(万元)	-1216.49	机构5日流向(万元)	-2566.79
机构10日流向(万元)	-5717.06	机构20日流向(万元)	-16725.11

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量增加1316.05万股，其中基金净增仓3家，主力净增仓16家，有一定的中长期投资价值。

截止2024-12-31，共209家主力机构（基金205家，一般法人3家，券商集合理财1家），持仓量总计25178.36万股，占流通A股32.93%
其中，基金持仓与2024-06-30相比：
增仓：61家，增持 911.39万股
减仓：58家，减持 631.78万股
新出现在主力名单中：79家，持有2110.23万股
从主力名单中消失：63家，原持有560.72万股

消息面诊股

诊断结果：5.5消息面打败了75%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2025-05-30
一般消息	募资投向		2025-04-03
一般消息	分红转增	不分配不转增	2025-03-28
利好	业绩预告	预计减亏	2025-01-18
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31
一般消息	高管变动	其他工作安排	2024-12-20
一般消息	高管变动	逝世	2024-10-23
一般消息	分红转增	不分配不转增	2024-08-31
一般消息	重大事项	关联交易	2024-08-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：4.2行业面打败了58%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2025.07.09","price":"-0.13","value":"-0.28"},{"date":"2025.07.08","price":"0.70","value":"0.18"},{"date":"2025.07.07","price":"0.02","value":"-1.65"},{"date":"2025.07.04","price":"0.32","value":"0.46"},{"date":"2025.07.03","price":"0.18","value":"2.86"},{"date":"2025.07.02","price":"-0.09","value":"-1.57"},{"date":"2025.07.01","price":"0.39","value":"2.52"},{"date":"2025.06.30","price":"0.59","value":"1.47"},{"date":"2025.06.27","price":"-0.70","value":"0.85"},{"date":"2025.06.26","price":"-0.22","value":"-1.31"},{"date":"2025.06.25","price":"1.03","value":"0.29"},{"date":"2025.06.24","price":"1.15","value":"1.81"},{"date":"2025.06.23","price":"0.65","value":"1.50"},{"date":"2025.06.20","price":"-0.07","value":"0.27"},{"date":"2025.06.19","price":"-0.79","value":"-1.80"},{"date":"2025.06.18","price":"0.04","value":"-1.20"},{"date":"2025.06.17","price":"-0.04","value":"-1.63"},{"date":"2025.06.16","price":"0.35","value":"-0.12"},{"date":"2025.06.13","price":"-0.75","value":"-2.82"},{"date":"2025.06.12","price":"0.01","value":"1.54"},{"date":"2025.06.11","price":"0.52","value":"-1.03"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	神州细胞	64.53%	25.98%	6.0分
2	百普赛斯	26.98%	-1.54%	5.5分
3	康辰药业	10.88%	15.60%	5.6分
4	ST未名	10.68%	1.22%	4.6分
5	荣昌生物	9.42%	5.26%	4.8分
6	赛升药业	9.28%	4.97%	4.7分
7	迈威生物	6.63%	6.44%	5.3分
8	义翘神州	5.95%	1.58%	4.8分
9	康华生物	5.41%	-0.66%	4.2分
10	派林生物	5.08%	-2.20%	4.1分
11	金迪克	4.99%	-0.07%	4.7分
12	沃森生物	4.91%	-1.60%	4.0分
13	优宁维	4.38%	3.55%	5.2分
14	康泰生物	4.36%	3.11%	4.8分
15	万泽股份	4.23%	-3.19%	4.9分
16	君实生物	3.58%	7.15%	5.6分
17	辽宁成大	3.02%	2.46%	4.9分
18	东宝生物	2.47%	2.11%	4.9分
19	博晖创新	2.47%	4.88%	5.1分
20	我武生物	2.45%	0.38%	4.9分
21	近岸蛋白	2.17%	1.10%	3.9分
22	华兰疫苗	1.50%	0.77%	5.0分
23	智飞生物	1.06%	1.21%	4.0分
24	通化东宝	0.64%	-2.72%	4.7分
25	百克生物	0.61%	1.33%	5.0分
26	卫光生物	0.52%	0.66%	4.9分
27	天坛生物	-0.10%	2.50%	5.1分
28	上海莱士	-0.29%	1.02%	4.6分
29	长春高新	-0.75%	5.51%	5.0分
30	西藏药业	-1.86%	0.82%	4.8分
31	诺唯赞	-2.02%	-0.31%	5.1分
32	康希诺	-2.16%	1.54%	4.6分
33	安科生物	-2.34%	1.74%	5.3分
34	华兰生物	-2.53%	0.38%	4.5分
35	博雅生物	-2.53%	1.20%	4.7分
36	凯因科技	-2.68%	1.92%	5.2分
37	诺诚健华	-3.57%	0.96%	4.7分
38	赛伦生物	-3.70%	1.40%	4.5分
39	百奥泰	-4.03%	1.56%	5.1分
40	特宝生物	-4.32%	-3.37%	4.7分
41	艾迪药业	-5.33%	-1.20%	5.2分
42	甘李药业	-5.50%	-1.91%	5.3分
43	*ST四环	-7.12%	0.40%	3.9分
44	康弘药业	-7.71%	0.10%	5.0分
45	欧林生物	-9.77%	-1.76%	4.6分
46	智翔金泰	-9.95%	2.16%	3.9分
47	三生国健	-10.19%	1.31%	5.4分
48	昊帆生物	-10.29%	-1.32%	4.3分
49	-	-14.94%	-0.12%	分
50	科兴制药	-16.98%	-8.91%	5.5分
51	成大生物	-	1.78%	5.2分
52	*ST双成	-	0.41%	4.1分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.5基本面打败了74%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-03-31 ]公司经营

盈利能力：尚可，接近行业平均，两项指标的行业排名分别为 46/72 ， 19/72。

[{"date":"2025-03-31","value":"-4.09","vol":"0.63"},{"date":"2024-12-31","value":"-19.69","vol":"-0.24"},{"date":"2024-09-30","value":"-13.91","vol":"1.37"},{"date":"2024-06-30","value":"-9.46","vol":"0.72"},{"date":"2024-03-31","value":"-4.04","vol":"0.41"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净资产收益率(%)	-4.09	-19.69	-13.91	-9.46	-4.04
行业(%)	0.63	-0.24	1.37	0.72	0.41

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"81.24","vol":"69.78"},{"date":"2024-12-31","value":"78.92","vol":"69.97"},{"date":"2024-09-30","value":"74.41","vol":"70.57"},{"date":"2024-06-30","value":"73.23","vol":"69.89"},{"date":"2024-03-31","value":"71.61","vol":"70.42"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
销售毛利率(%)	81.24	78.92	74.41	73.23	71.61
行业(%)	69.78	69.97	70.57	69.89	70.42

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，两项指标的行业排名分别为 8/72 ， 17/72。

[{"date":"2025-03-31","value":"31.46","vol":"6246.12"},{"date":"2024-12-31","value":"29.67","vol":"48.20"},{"date":"2024-09-30","value":"28.87","vol":"178.44"},{"date":"2024-06-30","value":"17.37","vol":"19.75"},{"date":"2024-03-31","value":"49.24","vol":"31.66"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
营业收入同比增长率(%)	31.46	29.67	28.87	17.37	49.24
行业(%)	6246.12	48.20	178.44	19.75	31.66

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"17.01","vol":"-7.36"},{"date":"2024-12-31","value":"43.90","vol":"-10.38"},{"date":"2024-09-30","value":"34.12","vol":"-53.42"},{"date":"2024-06-30","value":"35.34","vol":"-9.25"},{"date":"2024-03-31","value":"47.92","vol":"-535.57"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净利润同比增长率(%)	17.01	43.90	34.12	35.34	47.92
行业(%)	-7.36	-10.38	-53.42	-9.25	-535.57

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 27/72 ， 33/72。

[{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.18","vol":"0.29"},{"date":"2024-09-30","value":"0.11","vol":"0.22"},{"date":"2024-06-30","value":"0.07","vol":"0.14"},{"date":"2024-03-31","value":"0.03","vol":"0.07"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
总资产周转率(次)	0.05	0.18	0.11	0.07	0.03
行业(次)	0.06	0.29	0.22	0.14	0.07

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.16","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.19"},{"date":"2024-09-30","value":"0.59","vol":"0.87"},{"date":"2024-06-30","value":"0.39","vol":"0.55"},{"date":"2024-03-31","value":"0.20","vol":"0.26"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
存货增长率(次)	0.16	0.73	0.59	0.39	0.20
行业(次)	0.26	1.19	0.87	0.55	0.26

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-03-31","value":"-4.86","vol":"-47.52"},{"date":"2024-12-31","value":"-47.31","vol":"-9.01"},{"date":"2024-09-30","value":"-51.14","vol":"-29.47"},{"date":"2024-06-30","value":"-120.61","vol":"-36875.39"},{"date":"2024-03-31","value":"-98.89","vol":"-44804.94"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
现金流量净额/营业收入	-4.86	-47.31	-51.14	-120.61	-98.89
行业	-47.52	-9.01	-29.47	-36875.39	-44804.94

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.11","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.40","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资本支出／折旧和摊销	-	2.11	-	2.40	-
行业	0.00	2.00	0.00	2.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 7/72 ， 4/72。

[{"date":"2025-03-31","value":"1.40","vol":"7.90"},{"date":"2024-12-31","value":"1.72","vol":"6.83"},{"date":"2024-09-30","value":"2.00","vol":"7.16"},{"date":"2024-06-30","value":"2.11","vol":"7.04"},{"date":"2024-03-31","value":"2.09","vol":"8.08"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
流动比率	1.40	1.72	2.00	2.11	2.09
行业	7.90	6.83	7.16	7.04	8.08

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"1.13","vol":"6.47"},{"date":"2024-12-31","value":"1.40","vol":"5.50"},{"date":"2024-09-30","value":"1.62","vol":"5.77"},{"date":"2024-06-30","value":"1.73","vol":"5.91"},{"date":"2024-03-31","value":"1.78","vol":"6.93"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
速动比率	1.13	1.40	1.62	1.73	1.78
行业	6.47	5.50	5.77	5.91	6.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 1/72 ， 8/72。

[{"date":"2025-03-31","value":"47.98","vol":"25.48"},{"date":"2024-12-31","value":"44.98","vol":"25.46"},{"date":"2024-09-30","value":"42.16","vol":"24.92"},{"date":"2024-06-30","value":"39.90","vol":"24.62"},{"date":"2024-03-31","value":"41.63","vol":"23.98"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资产负债率(%)	47.98	44.98	42.16	39.90	41.63
行业(%)	25.48	25.46	24.92	24.62	23.98

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.93","vol":"0.78"},{"date":"2024-12-31","value":"0.83","vol":"0.88"},{"date":"2024-09-30","value":"0.74","vol":"0.41"},{"date":"2024-06-30","value":"0.68","vol":"0.38"},{"date":"2024-03-31","value":"0.73","vol":"0.36"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
产权比率 (%)	0.93	0.83	0.74	0.68	0.73
行业(%)	0.78	0.88	0.41	0.38	0.36

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
方正证券	2025-06-19	买入	买入
太平洋	2025-04-30	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"-7.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-23.88","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-22.83","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-12.81","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-6.91","blueLineValue":"-0.70","type":"YC"}]

[君实生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]